tradingkey.logo
tradingkey.logo
Search

Galmed Pharmaceuticals Ltd

GLMD
Add to Watchlist
3.480USD
+0.070+2.05%
Close 09-09 16:00ET
3.75MMarket Cap
LossP/E TTM

GLMD Financials

See Galmed Pharmaceuticals Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
3.75M
Dividend TTM
0.00
P/E TTM
-1.90
EPS TTM
-2.39
Revenue
--
Net Profit
-7.52M
ROE
-64.21%
ROA
-55.53%

Galmed Pharmaceuticals Ltd Earnings Date

Latest Release
Sep 2, 2026
EPS / Forecast
--/-3.12
Revenue / Forecast
--/--

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-352.54%-2.86
-273.70%-2.32
59.89%-0.80
84.98%-0.35
70.38%-0.63
77.86%-0.62
88.19%-2.00
18.46%-2.31
81.25%-2.13
78.56%-2.80
10.27%-16.91
92.60%-2.83
---11.38
---13.07
---18.85
---38.23
----
----
----
----
Net Profit
-9.14%-2.72M
-73.01%-1.91M
-50.14%-4.82M
1.15%-1.89M
-122.97%-2.50M
13.41%-1.10M
-59.18%-3.21M
-29.94%-1.91M
29.76%-1.12M
30.33%-1.27M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
64.59%-2.64M
30.65%-5.35M
55.53%-3.73M
31.02%-6.14M
27.49%-7.45M
-11.72%-7.71M
Operating profit
-31.58%-2.77M
-61.71%-2.04M
-85.04%-3.04M
-4.18%-2.10M
-72.59%-2.11M
9.78%-1.26M
23.57%-1.64M
-36.99%-2.01M
34.69%-1.22M
30.02%-1.40M
12.17%-2.15M
72.71%-1.47M
49.84%-1.87M
67.14%-2.00M
67.31%-2.45M
31.42%-5.38M
55.66%-3.73M
33.29%-6.09M
27.56%-7.49M
-3.36%-7.84M
Net Profit
-9.14%-2.72M
-73.01%-1.91M
-50.14%-4.82M
1.15%-1.89M
-122.97%-2.50M
13.41%-1.10M
-59.18%-3.21M
-29.94%-1.91M
29.76%-1.12M
30.33%-1.27M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
64.59%-2.64M
30.65%-5.35M
55.53%-3.73M
31.02%-6.14M
27.49%-7.45M
-11.72%-7.71M
Current assets
-44.45%11.71M
-1.66%16.03M
15.52%18.63M
11.53%19.72M
109.25%21.08M
45.75%16.30M
21.79%16.12M
24.56%17.68M
2.96%10.08M
-12.87%11.18M
-10.09%13.24M
-30.67%14.20M
-57.69%9.79M
-56.79%12.83M
-59.16%14.72M
-53.13%20.48M
-55.23%23.13M
-50.25%29.70M
-30.41%36.05M
-26.37%43.69M
Total current liabilities
16.23%2.81M
15.05%2.08M
30.92%2.85M
-1.67%2.47M
55.79%2.42M
2.38%1.81M
-20.98%2.17M
20.23%2.51M
-42.93%1.55M
-36.99%1.77M
-11.12%2.75M
-58.44%2.09M
-0.22%2.72M
-50.40%2.80M
-47.37%3.09M
-20.75%5.03M
-61.06%2.73M
-20.88%5.65M
-26.62%5.88M
4.93%6.35M
Total assets
-20.31%18.28M
-14.22%16.03M
0.69%18.63M
3.03%21.58M
71.98%22.94M
28.67%18.68M
11.25%18.50M
18.78%20.95M
0.48%13.34M
-1.83%14.52M
0.41%16.63M
-15.48%17.64M
-43.68%13.28M
-51.02%14.79M
-54.76%16.56M
-52.89%20.87M
-54.95%23.57M
-49.99%30.20M
-30.12%36.60M
-26.11%44.30M
Total liabilities
129.04%5.54M
15.05%2.08M
30.92%2.85M
-1.67%2.47M
55.79%2.42M
2.38%1.81M
-20.98%2.17M
20.23%2.51M
-42.93%1.55M
-36.99%1.77M
-12.36%2.75M
-59.16%2.09M
-4.89%2.72M
-51.96%2.80M
-48.62%3.14M
-22.68%5.12M
-60.92%2.86M
-21.43%5.83M
-25.77%6.11M
5.16%6.62M
Total equity
-37.93%12.74M
-17.35%13.95M
-3.34%15.78M
3.67%19.11M
74.12%20.52M
32.31%16.88M
17.64%16.33M
18.58%18.44M
11.68%11.79M
6.39%12.76M
3.40%13.88M
-1.28%15.55M
-49.04%10.55M
-50.79%11.99M
-55.99%13.42M
-58.20%15.75M
-53.97%20.71M
-53.99%24.37M
-30.93%30.50M
-29.78%37.68M
Net operating income
-67.74%-2.13M
-117.31%-2.54M
1.22%-1.95M
-81.86%-1.94M
-24.68%-1.27M
36.23%-1.17M
-119.27%-1.97M
51.13%-1.06M
25.60%-1.02M
-7.96%-1.83M
77.68%-898.00K
30.09%-2.18M
76.87%-1.37M
68.91%-1.69M
42.43%-4.02M
65.34%-3.11M
22.54%-5.91M
41.29%-5.45M
10.82%-6.99M
-60.25%-8.98M
Net investment
149.09%2.24M
165.80%152.00K
140.24%1.43M
-100.49%-3.00K
-428.23%-4.57M
-153.47%-231.00K
-255.73%-3.55M
117.37%614.00K
97.45%1.39M
-68.02%432.00K
15.16%2.28M
-168.98%-3.54M
-83.01%705.00K
-78.59%1.35M
-69.01%1.98M
12.59%5.13M
91.33%4.15M
483.76%6.31M
442.73%6.38M
-71.54%4.55M
Net financing
-80.07%1.20M
-100.00%0.00
165.18%1.19M
-96.53%289.00K
--6.04M
--1.51M
--448.00K
34.81%8.34M
----
----
--0.00
8735.71%6.18M
----
----
--0.00
--70.00K
--0.00
-100.00%0.00
--0.00
-100.00%0.00

FAQs

What are the current assets of Galmed Pharmaceuticals Ltd?

According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its current assets were 18.63M, with a year-on-year change of 15.52.

What are the total assets of Galmed Pharmaceuticals Ltd?

According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its total assets of Galmed Pharmaceuticals Ltd were 18.63M, with a year-on-year change of 0.69.

What are the total liabilities of Galmed Pharmaceuticals Ltd?

According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its total liabilities of Galmed Pharmaceuticals Ltd were 2.85M, with a year-on-year change of 30.92.

What is the total equity of Galmed Pharmaceuticals Ltd?

According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its total equity of Galmed Pharmaceuticals Ltd was 15.78M, with a year-on-year change of -3.34.

What is the net operating income of Galmed Pharmaceuticals Ltd?

According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its net operating income of Galmed Pharmaceuticals Ltd was -8.51M, with a year-on-year change of -35.55.

What is the net investment of Galmed Pharmaceuticals Ltd?

According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its net investment of Galmed Pharmaceuticals Ltd was -3.38M, with a year-on-year change of -203.78.

What is the net financing of Galmed Pharmaceuticals Ltd?

According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its net financing of Galmed Pharmaceuticals Ltd was 9.03M, with a year-on-year change of 2.73.

What is the Earnings Per Share (EPS) of Galmed Pharmaceuticals Ltd?

According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -19.13, with a year-on-year change of -136.87.

What is the net income of Galmed Pharmaceuticals Ltd?

According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its net income was -10.31M, with a year-on-year change of -37.14.

What is the Return on Equity (ROE) of Galmed Pharmaceuticals Ltd?

According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its Return on Equity (ROE) was -64.21, with a year-on-year change of -29.01.

What is the Return on Assets (ROA) of Galmed Pharmaceuticals Ltd?

According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its Return on Assets (ROA) was -55.53, with a year-on-year change of -29.76.

What is the operating profit of Galmed Pharmaceuticals Ltd?

According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its operating profit was -8.51M, with a year-on-year change of -35.55.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.